Morice, M.C., Serruys, P.W., Kappetein, A.P., Feldman, T.E., Ståhle, E., Colombo, A., Mack, M.J., Holmes, D.R., Torracca, L., van Es, G.A., Leadley, K., Dawkins, K.D. and Mohr, F. (2010) Outcomes in Patients with de Novo Left Main Disease Treated with either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) Trial. Circulation, 121, 2645-2653. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.899211

has been cited by the following article:

• TITLE: Review: Outcomes of Revascularization Strategies for Coronary Artery Disease

  AUTHORS: Turki B. Albacker, Hanan Albackr, Mostafa Al Shamiri, Abdulelah F. Al Mobeirek

  KEYWORDS: Outcomes; Revascularization; Coronary Artery Bypass Grafting; Percutaneous Coronary Intervention; Survival; Major Adverse Cardiovascular; Cerebrovascular Events

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.5 No.5, March 21, 2014

  ABSTRACT: The optimal revascularization strategy for patients with coronary artery disease is influenced by the continuous improvement in medical therapy and the improved designs of the new generation of coronary stents allowing them to be increasingly applied in patients with complex coronary anatomy, including those with left main stem disease. On the other hand, surgical results are also improved as a result of the increased experience over years and the improvement of myocardial protection techniques. This will make the comparison of percutaneous coronary interventions and coronary artery bypass surgery a moving target. In this paper, we reviewed the recent randomized controlled trials and important registries emphasizing the benefits and the results of each therapy in different patient subsets. A heart team of both cardiologists and cardiac surgeons is of paramount importance in choosing the optimal revascularization strategy.